Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
AAPS PharmSciTech ; 11(4): 1508-10, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20936439

ABSTRACT

The bead sizes used in approved modified release capsules labeled for sprinkling on food was investigated to generate bead size guidelines for generic products labeled for sprinkling. The conclusions from a survey of FDA databases were corroborated with experimental data obtained by measuring the bead sizes of several reference-listed drugs on the market labeled for administration by sprinkling on food. The experimental data show that majority of the marketed products were found to have bead sizes of less than 1,500 microm (1.5 mm). Based on this information, a bead size of less than 1,500 microm should generally be considered acceptable for use in generic products labeled for sprinkling.


Subject(s)
Capsules , Delayed-Action Preparations/chemistry , Particle Size , Pharmaceutical Preparations/administration & dosage , Administration, Oral , Databases, Factual , Drug Approval , Food , Hydrogen-Ion Concentration , Pharmaceutical Preparations/chemistry , Therapeutic Equivalency , United States , United States Food and Drug Administration
2.
J Chromatogr A ; 1217(48): 7547-55, 2010 Nov 26.
Article in English | MEDLINE | ID: mdl-20980012

ABSTRACT

A high-pressure liquid chromatography-diode array detection and multi-mode ionization tandem mass spectrometry (HPLC-DAD-MMI-MS/MS) method was used to identify amino-tadalafil and rimonabant in electronic cigarette (e-cigarette) cartridges. Amino-tadalafil is a drug analogue of the commercially approved Cialis™ (i.e. tadalafil). Rimonabant is a drug that was, at one time, approved for weight loss in Europe (although approval has been retracted), but not in the United States. In addition, poor quality control over the e-cigarette products analyzed here is shown by the presence of nicotine in products labeled as containing no nicotine or by the presence of significant amounts of rimonabant oxidative degradant in e-cigarette products containing rimonabant. Identification was accomplished by comparing the retention time of relevant peaks in the sample with those of standard compounds, in addition to comparison of the UV spectra, mass spectra and/or product ion mass spectra.


Subject(s)
Carbolines/analysis , Chromatography, High Pressure Liquid/methods , Piperidines/analysis , Pyrazoles/analysis , Tandem Mass Spectrometry/methods , Tobacco, Smokeless/analysis , Rimonabant , Tadalafil , Tandem Mass Spectrometry/instrumentation
SELECTION OF CITATIONS
SEARCH DETAIL
...